Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Retained Earnings (2019 - 2025)

Outset Medical (OM) has disclosed Retained Earnings for 7 consecutive years, with -$1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 2789090.48% to -$1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 billion, a 2789090.48% decrease, with the full-year FY2025 number at -$1.2 billion, down 2789090.48% from a year prior.
  • Retained Earnings was -$1.2 billion for Q4 2025 at Outset Medical, up from -$1.2 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $68000.0 in Q4 2023 to a low of -$1.2 billion in Q3 2025.
  • A 5-year average of -$660.9 million and a median of -$768.2 million in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: tumbled 62599500.0% in 2021, then soared 100.01% in 2023.
  • Outset Medical's Retained Earnings stood at -$626.0 million in 2021, then decreased by 26.03% to -$788.9 million in 2022, then surged by 100.01% to $68000.0 in 2023, then tumbled by 38.24% to $42000.0 in 2024, then tumbled by 2789090.48% to -$1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for OM's Retained Earnings are -$1.2 billion (Q4 2025), -$1.2 billion (Q3 2025), and -$1.1 billion (Q2 2025).